Tosca Debt Capital exits £90m maiden fund

3 May 2022

Must read

standard.co.uk

Tosca Debt Capital (TDC) maiden fund, Fund I, has now been fully realised, exiting the 10 businesses in its portfolio. TDC’s £90m Fund I was established to provide more options…

The post Tosca Debt Capital exits £90m maiden fund appeared first on London Business News | Londonlovesbusiness.com.

» Read More

Tags
Business News
finance

Five ways to make your business more sustainable

The West told they must ‘gear itself up’ for ‘worst case scenario’ as Putin could formally declare war against Ukraine

Germany ranks as the worst G10 nation for real wage growth with UK sitting mid-table

Government needs to take action as 80% of UK drivers won’t buy electric vehicles due to rise in electricity costs

EverCraft Ecotechnologies creates future market with innovative solution from ecoCNTs

Unilever raises full-year sales forecasts after price hike

What is an after dinner speaker and what do they do

Germany ranks as the worst G10 nation for real wage growth with UK sitting mid-table

Government needs to take action as 80% of UK drivers won’t buy electric vehicles due to rise in electricity costs

EverCraft Ecotechnologies creates future market with innovative solution from ecoCNTs

Unilever raises full-year sales forecasts after price hike

What is an after dinner speaker and what do they do

Tosca Debt Capital exits £90m maiden fund

Must read

Study reveals hidden mental health symptoms in people with autoimmune diseases

Large dusty clumps around young star provide insight into how planets are born

Can You Really Offset Your Carbon Footprint From Flying?

Michael Gove: Labour energy policy would ‘give jobs to Russian workers’

Latest article

Study reveals hidden mental health symptoms in people with autoimmune diseases

Large dusty clumps around young star provide insight into how planets are born

Can You Really Offset Your Carbon Footprint From Flying?

Michael Gove: Labour energy policy would ‘give jobs to Russian workers’

New immunotherapy drug shows promise as cancer treatment, research suggests